These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 15328337)
1. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Collin M; Rossi A; Cuzzocrea S; Patel NS; Di Paola R; Hadley J; Collino M; Sautebin L; Thiemermann C J Leukoc Biol; 2004 Nov; 76(5):961-70. PubMed ID: 15328337 [TBL] [Abstract][Full Text] [Related]
2. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Patel NS; Cuzzocrea S; Chatterjee PK; Di Paola R; Sautebin L; Britti D; Thiemermann C Mol Pharmacol; 2004 Aug; 66(2):220-7. PubMed ID: 15266012 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Collin M; Anuar FB; Murch O; Bhatia M; Moore PK; Thiemermann C Br J Pharmacol; 2005 Oct; 146(4):498-505. PubMed ID: 16100527 [TBL] [Abstract][Full Text] [Related]
4. Effect of calpain inhibitor I, an inhibitor of the proteolysis of I kappa B, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Ruetten H; Thiemermann C Br J Pharmacol; 1997 Jun; 121(4):695-704. PubMed ID: 9208136 [TBL] [Abstract][Full Text] [Related]
5. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. Crespo E; Macías M; Pozo D; Escames G; Martín M; Vives F; Guerrero JM; Acuña-Castroviejo D FASEB J; 1999 Sep; 13(12):1537-46. PubMed ID: 10463945 [TBL] [Abstract][Full Text] [Related]
6. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Ruetten H; Thiemermann C Br J Pharmacol; 1997 Sep; 122(1):59-70. PubMed ID: 9298529 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Ruetten H; Southan GJ; Abate A; Thiemermann C Br J Pharmacol; 1996 May; 118(2):261-70. PubMed ID: 8735625 [TBL] [Abstract][Full Text] [Related]
8. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Collin M; Patel NS; Dugo L; Thiemermann C Crit Care Med; 2004 Mar; 32(3):826-31. PubMed ID: 15090969 [TBL] [Abstract][Full Text] [Related]
9. The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Rossi A; Pergola C; Koeberle A; Hoffmann M; Dehm F; Bramanti P; Cuzzocrea S; Werz O; Sautebin L Br J Pharmacol; 2010 Oct; 161(3):555-70. PubMed ID: 20880396 [TBL] [Abstract][Full Text] [Related]
10. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala EM; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C Crit Care Med; 2005 Sep; 33(9):1903-12. PubMed ID: 16148458 [TBL] [Abstract][Full Text] [Related]
11. Effect of anthocyanins contained in a blackberry extract on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Sautebin L; Rossi A; Serraino I; Dugo P; Di Paola R; Mondello L; Genovese T; Britti D; Peli A; Dugo G; Caputi AP; Cuzzocrea S Planta Med; 2004 Aug; 70(8):745-52. PubMed ID: 15368665 [TBL] [Abstract][Full Text] [Related]
12. Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin. Wray GM; Hinds CJ; Thiemermann C Shock; 1998 Jul; 10(1):13-9. PubMed ID: 9688085 [TBL] [Abstract][Full Text] [Related]
13. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors. Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198 [TBL] [Abstract][Full Text] [Related]
14. 5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9. Tu XK; Yang WZ; Shi SS; Chen CM; Wang CH Neurol Res; 2009 Oct; 31(8):848-52. PubMed ID: 19309543 [TBL] [Abstract][Full Text] [Related]
15. 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma. Xu XM; Deng JJ; Yuan GJ; Yang F; Guo HT; Xiang M; Ge W; Wu YG Mol Med Rep; 2011; 4(6):1195-200. PubMed ID: 21833474 [TBL] [Abstract][Full Text] [Related]
16. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137 [TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4/leukotriene B4 receptor pathway is involved in hepatic microcirculatory dysfunction elicited by endotoxin. Ito S; Ito Y; Katagiri H; Suzuki T; Hoka S; Yokomizo T; Shimizu T; Majima M Shock; 2008 Jul; 30(1):87-91. PubMed ID: 18004232 [TBL] [Abstract][Full Text] [Related]
18. Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat. Murch O; Abdelrahman M; Collino M; Gallicchio M; Benetti E; Mazzon E; Fantozzi R; Cuzzocrea S; Thiemermann C Crit Care Med; 2008 Feb; 36(2):550-9. PubMed ID: 18216604 [TBL] [Abstract][Full Text] [Related]
19. Role of preprotachykinin-A gene products on multiple organ injury in LPS-induced endotoxemia. Ng SW; Zhang H; Hegde A; Bhatia M J Leukoc Biol; 2008 Feb; 83(2):288-95. PubMed ID: 17998302 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats. Yamano M; Umeda M; Miyata K; Yamada T Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):253-63. PubMed ID: 9750012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]